Once-daily and twice-daily dosing of p-aminosalicylic acid granules

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 3, 1999, Pages 932-934

  Peloquin, Charles A ^a   Berning, Shaun E ^a   Huitt, Gwen A ^a   Childs, James M ^a   Singleton, Michael D ^a   James, Gordon T ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG EFFECT; DRUG HALF LIFE; DRUG RELEASE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; PRIORITY JOURNAL;

EID: 0032986001     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.3.9807131     Document Type: Article

References (7)

1. 1. Peloquin, C. A., T. L. Henshaw, G. A. Huitt, S. E. Berning, A. T. Nitta, and G. T. James. 1994. Pharmacokinetic evaluation of p-aminosalicylic acid granules. Pharmacother. 14:40-46. Erratum: Pharmacother. 1994;14:P-2.
2. 2. Fujiwara, P. I., C. Larkin, and T. R. Frieden. 1997. Directly observed therapy in New York City. Clin. Chest Med. 18:135-148.
3. 3. Weis, S. E. 1997. Universal directly observed therapy. Clin. Chest Med. 18:155-163.
4. 4. Berning, S., G. Huitt, and C. A. Peloquin. 1998. Pharmacokinetics (PK) of p-aminosalicylic acid (PAS) granules dosed every (Q) 12 or 24 hours (h) (abstract). Am. J. Respir. Crit. Care Med. 157:A467.
5. 5. Peloquin, C. A. 1997. Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clin. Chest Med. 18:79-87.
6. 6. Heifets, L. B. 1991. Antituberculosis drugs: anti-microbial activity in vitro. In L. B. Heifets, editor. Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. CRC Press, Boca Raton, FL. 13-58.
7. 7. Berning, S. E., and C. A. Peloquin. 1998. Antimycobacterial agents: para-aminosalicylic acid. In V. L. Yu, T. C. Merigan, S. Barriere, and N. J. White, editors. Antimicrobial Chemotherapy. Williams and Wilkins, Baltimore, MD. 663-668.